Portfolio Q2'26 Earnings Review — 20 Holdings, 6 External Peers, One Selection (Portfolio Q2 Earnings Sector)
Executive Summary & Action Plan
Verdict
NEUTRAL / REBALANCE — operating evidence is strong, but price expectations and cash-conversion risk are uneven. Keep the portfolio thesis and do not chase the aggregate basket. Top Pick: Microsoft (MSFT), an external peer, after comparing all 26 names on the same five-part scorecard.
Abstract
This review covers every operating company in the refreshed portfolio and six major peers, with ITA excluded and no confidential position data used. Twenty-one companies have reported the June-aligned quarter; NVIDIA, Micron, Marvell, Broadcom, and Planet Labs remain pending, so their latest available quarters are labeled rather than passed off as Q2 results. Eleven reporters raised or clearly strengthened guidance, and demand expanded across compute, memory, optics, power, cloud, and space. Valuation is the constraint: only four of 26 names have positive upside to the audited Base fair value, and the median gap is -16.2%. Several fast growers still consume cash, depend on customer advances, or carry peak-cycle margins after exceptional YTD gains. Microsoft remains the coherent selection because revenue rose 18%, Azure grew 43%, commercial RPO reached $678B, the next-quarter Azure outlook accelerated to about 45%, and FCF stayed positive. The aggregate stance is selective, not broadly bullish.
Forecast Path
The scoreable target is a frozen 20-company basket: 5% initial weight per security, distributions reinvested, no rebalancing, and corporate actions handled by the resolution rule. The Base path assumes the four pending reports broadly validate current demand; the Bear path reflects simultaneous guide cuts and multiple compression after a median +33.6% YTD portfolio move; the Bull path requires broader cash conversion, not merely revenue beats. Probabilities vary by horizon in the prediction sidecar; the chart displays the 12M vector.
Action Plan
- Hold aggregate risk near neutral until the five pending reports settle; do not infer trades from actual portfolio weights, which were not used.
- Stage incremental exposure in thirds: after the August 26–September 3 report window, after the first Q3 guide reset, and only after cash conversion confirms the revenue signal.
- Rebalance single-name concentration created by extreme YTD winners; use the equal-weight basket as the research benchmark, not as a mandate to sell every outperformer.
- Add MSFT to the focused research list as Top Pick; require Azure growth near the guided level, ex-frontier-customer backlog breadth, and positive FCF before upgrading conviction.
- Treat constituent Base fair values as 12-month decision anchors, not as the portfolio forecast; rebuild each pending name after its next release before acting on the gap.
- Re-underwrite immediately if two of the five pending companies cut demand guidance or the basket reaches the 1M Bear level.
State of the Sector
The common factor is AI infrastructure, but the earnings quality is not common. Merchant compute and foundry remain strong; memory and storage show peak-cycle economics; optics and power are converting backlog into revenue; hyperscalers are growing while FCF absorbs capex; space names are scaling revenue but still rely on external capital or customer advances. The correct portfolio question is therefore not “did AI demand grow?” It did. The question is which companies convert that demand into durable cash without requiring a perfect multiple.
Forecast Drivers & Cycle Map
Selection & Dispersion
Score = reporting integrity (20%), revenue/earnings quality (25%), guidance (25%), cash/balance sheet (20%), and expectations/risk (10%). Prices are the cross-checked 2026-08-13 U.S. close. “Base FV / 12M target” is the rounded, self-derived fair-value anchor under a one-year convergence assumption; Street targets receive zero weight. Bear and Bull are scenario anchors, not a statistical interval. “Pending” names remain capped until the next release.
What to Watch Now
The next five releases are portfolio-level events, not routine updates: NVIDIA on August 26 and Planet Labs on September 3 are confirmed; Marvell around August 27, Broadcom around September 3, and Micron in late September remain estimates. Treat the first four semiconductor prints as an AI-demand breadth test and Planet as the missing space-data quarter. The decisive evidence is next-quarter revenue and margin guidance, not headline EPS.
What to Watch Next (Technology/Structure)
By the next full reporting cycle, track whether AI capex converts into cloud revenue and cash, whether memory gross margins normalize without collapsing, and whether power/optics backlogs convert without deposit reversals. In space, distinguish launch and constellation execution from long-dated addressable-market claims. Across the whole book, supplier concentration and financing terms matter more than aggregate demand headlines.
Allocation & Selection Notes
MSFT remains the selection because it is the only high-confidence, top-tier candidate combining a completed June quarter, accelerating core guidance, broad backlog, positive FCF, and a positive Base gap. META has a slightly larger gap but lower confidence because capex, legal exposure and Reality Labs widen the range; AVGO is report-pending and RDW is dilution-sensitive. These constituent marks are comparison evidence, not a portfolio-level Fair Value, so the root forecast remains the frozen 20-name basket.
Catalysts, Leading Indicators & Risks
Falsification & Review Rules
- Aggregate Base thesis fails if the normalized basket resolves at or below 88 at 1M, or if two of the five pending reporters cut demand guidance.
- The MSFT selection is re-opened if Azure misses 40% growth, non-frontier backlog breadth reverses, or FCF turns negative without a bounded capacity explanation.
- Move to Bear if at least eight of the 20 portfolio companies show worsening cash conversion for two consecutive reported quarters.
- Review probabilities after each of the five pending reports, then monthly for breadth and quarterly for operating evidence; never revise probabilities from price alone.
References
면책사항 · 본 IC 메모는 IWANNAVY LAB의 내부 투자 리서치 자료이며, 공개된 정보와 에이전트 기반 분석을 종합한 교육·연구 목적 문서입니다. 투자 권유·매수/매도 추천이 아니며, 모든 투자 판단과 책임은 투자자 본인에게 있습니다. 가격 데이터는 yfinance + Finviz Elite 교차검증으로 2026-08-14 기준이며, 시장 동향에 따라 실시간 변동할 수 있습니다.
Comments are public. Posting is limited to paid members.
Posting is available on LAB Pro
Sign in, then upgrade to join the discussion.
Loading comments...